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Abstract: Psidium guajava L. is widely used like food and in folk medicine all around the world.
Many studies have demonstrated that guava leaves have anti-hyperglycemic and anti-hyperlipidemic
activities, among others, and that these activities belong mainly to phenolic compounds, although it
is known that phenolic composition in guava tree varies throughout seasonal changes. Andalusia
is one of the regions in Europe where guava is grown, thus, the aim of this work was to study the
phenolic compounds present in Andalusian guava leaves at different oxidation states (low, medium,
and high). The phenolic compounds in guava leaves were determined by HPLC-DAD-ESI-QTOF-MS.
The results obtained by chromatographic analysis reported that guava leaves with low degree of
oxidation had a higher content of flavonols, gallic, and ellagic derivatives compared to the other
two guava leaf samples. Contrary, high oxidation state guava leaves reported the highest content
of cyanidin-glucoside that was 2.6 and 15 times higher than guava leaves with medium and low
oxidation state, respectively. The QTOF platform permitted the determination of several phenolic
compounds with anti-diabetic properties and provided new information about guava leaf phenolic
composition that could be useful for nutraceutical production.
Keywords: Psidium guajava L.; HPLC-DAD-ESI-QTOF-MS; phenolic compounds; gallic and ellagic
derivatives; flavonols; cyanidin-glucoside
1. Introduction
Psidium guajava (P. guajava) L., from the Myrtaceae family, is common throughout tropical and
subtropical areas [1] and Andalusia is one of the regions in Europe where guava is grown. Moreover,
it is widely used like food and in folk medicine all around the world. Many studies have demonstrated
that guava leaves have anti-hyperglycemic and anti-hyperlipidemic activities [2–4], among others,
and these biological activities have mainly been related to the phenolic compounds [5].
Nowadays, alternative therapeutic strategies based on the use of phenolic compounds in food
products as “functional foods” and “nutraceuticals” are being developed. In fact, the capacity of
plant-derived foods to reduce the risk of chronic diseases has been demonstrated [6].
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It is known that P. guajava L. shows different phenological stages throughout its vegetative period
in response to environmental conditions [7], because of that, it has been seen that the accumulation
of specific compounds such as anthocyanins changes [8]. Furthermore, the response of the different
classes of phenolic compounds, especially flavonoids, also vary substantially [9]. This fact plays an
important role in finding the best conditions of the leaf in order to obtain the best recovery of the
target compounds for the development of a promising alternative source for ameliorating diabetes
complications [2–4].
In this sense, spectrophotometric analyses are still helpful for a preliminary identification and
quantification [10]; however, LC-MS has opened up new approaches for the structural characterization
of target compounds. Moreover, LC-TOF-MS can provide tentative identification of unknown peaks,
due to accurate-mass measurement [11]. So, both UV-VIS diode array and mass spectrometry coupled
to HPLC have been proved as most appropriate analytical techniques for phenolic compounds in
many matrices [10,11]. Concerning guava leaves, most of the literature shows that quantification of
the different classes of phenolic compounds is generally done via spectrophotometric analysis [12–15],
although different analytical techniques, such as LC-DAD and LC-DAD-MS, are used to characterize
the bioactive compounds present in guava leaves [3,4,16,17].
Despite these facts and to our knowledge, there is no literature taking into account the change
that climatic conditions cause in phenolic composition and this information would be useful to choose
the best raw material for nutraceutical scopes. Thus, the aim of this work was to study the phenolic
compounds present in Andalusian guava leaves at different oxidation states (low, medium, and high)
by HPLC-DAD-ESI-QTOF-MS.
2. Results and Discussion
2.1. Characterization of Phenolic Compounds
The HPLC-DAD-ESI-QTOF-MS analyses in negative mode permitted the identification and
quantification of seventy-three phenolic compounds in guava leaves [18]. The individual compounds
were quantified on the basis of their peak area and compared with calibration curves obtained with the
corresponding standards and then expressed as µg/g of leaf dry weight (d.w.). Moreover, quantification
of compounds for which no commercial standards were available, was achieved comparing with
standard compounds bearing similar structures (Table 1).
Furthermore, the analysis in positive mode allowed the identification of an anthocyanin
compound. The compound, with m/z 449.1090 presented its maximum of absorption at 280, 350, and
520 nm on the UV spectrum. The MS/MS analysis produced a fragment ion at 287 m/z corresponding
to the loss of hexose unit (Figure 1). Due to the UV and MS spectrum and by co-elution with a
commercial standard, this component has been identified as cyanidin-3-O-glucoside. To our knowledge,
this compound has been identified for the first time in guava leaves. Limits of detection (LOD) and
quantification (LOQ) calculated for the cyanidin-3-O-β-galactopyranoside standard were 0.007 and
0.024 mg/L.
In terms of concentration of the individual compounds (Table 1), in negative mode, leaves with
lower oxidation state exhibited the highest amounts for almost all compounds quantified, followed by
moderate oxidized leaves and, finally, highly oxidized leaves. Concentrations of several compounds
tentatively identified [18], such as procyanidin tetramer and pentamer, galloyl-(epi)catechin trimer
isomers 1 and 2, and quercetin glucuronide were found to be lower than the quantification limit
for all samples. In contrast, and as it was expected due to the red coloration of the leaves at
high oxidative state, in positive mode, opposite results were found (Table 1); the concentration
of cyanidin-3-O-glucoside increased as the oxidation state of the leaves increased. At low oxidative
state, the concentration of cyanidin-3-O-glucoside was 29.5 ˘ 0.2 µg/g leaf d.w. and it raised until
441.28 ˘ 0.04 µg/g leaf d.w. for the highest oxidation state.
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Table 1. Quantification (mean ˘ standard deviation (SD), n = 3) by HPLC-DAD-ESI-QTOF-MS in
negative and positive mode of individual compound tentatively identified in P. guajava leaves for the
different oxidative states.
No. Compound High Medium Low
Negative mode Concentration (µg compound/g leaf d.w.)
1 HHDP glucose Isomer 526 ˘ 2 c 651 ˘ 19 b 936 ˘ 10 a
2 HHDP glucose Isomer 505 ˘ 3 c 645 ˘ 3 b 823 ˘ 16 a
3 HHDP glucose Isomer 510 ˘ 11 c 645 ˘ 20 b 934 ˘ 2 a
4 Prodelphinidin B Isomer 447.1 ˘ 0.1 c 515.7 ˘ 0.4 b 715 ˘ 13 a
5 Gallic acid 153.52 ˘ 0.09 c 164 ˘ 3 b 175.9 ˘ 0.7 a
6 Pedunculagin/Casuariin Isomer 158.8 ˘ 0.6 b 163.84 ˘ 0.06 b 175 ˘ 3 a
7 Pedunculagin/Casuariin Isomer 464.0 ˘ 0.8 c 475.5 ˘ 0.5 b 557 ˘ 2 a
8 Prodelphinidin Dimer Isomer 497 ˘ 1 b 529 ˘ 6 b 603 ˘ 30 a
9 Gallocatechin 4913 ˘ 47 a 4435 ˘ 7 b 4098 ˘ 84 c
10 Vescalagin/castalagin Isomer 157.59 ˘ 0.01 a 136.6 ˘ 0.3 c 143 ˘ 2 b
11 Prodelphinidin Dimer Isomer 1365 ˘ 7 c 1560 ˘ 14 b 1739 ˘ 25 a
12 Uralenneoside 2464 ˘ 4 a 1911 ˘ 24 b 1872 ˘ 81 b
13 Geraniin Isomer 241 ˘ 1 b 264.9 ˘ 0.5 b 343 ˘ 25 a
14 Pedunculagin/Casuariin Isomer 466 ˘ 3 c 575 ˘ 16 b 683 ˘ 20 a
15 Geraniin Isomer 260 ˘ 3 b 290 ˘ 7 a,b 356 ˘ 48 a
16 Procyanidin B Isomer 4262 ˘ 12 c 4742 ˘ 15 b 5514 ˘ 69 a
17 Galloyl(epi)catechin-(epi)gallocatechin <LOQ 12.60 ˘ 0.07 b 38 ˘ 3 a
18 Procyanidin B Isomer 650 ˘ 3 c 708 ˘ 11 b 757 ˘ 23 a
19 Tellimagrandin I Isomer 347 ˘ 4 c 367.2 ˘ 0.7 b 397 ˘ 2 a
20 Pterocarinin A Isomer 569 ˘ 31 b 617 ˘ 9 b 679 ˘ 7 a
21 Pterocarinin A Isomer 316 ˘ 2 c 360 ˘ 4 b 376 ˘ 4 a
22 Stenophyllanin A 853 ˘ 13 c 1036 ˘ 50 b 1318 ˘ 24 a
23 Procyanidin trimer Isomer 781 ˘ 1 a 706 ˘ 1 c 738 ˘ 4 b
24 Catechin 8486 ˘ 10 b 8957 ˘ 11 a 6845 ˘ 24 c
25 Procyanidin tetramer <LOQ <LOQ <LOQ
26 Procyanidin trimer Isomer 89 ˘ 2 c 108 ˘ 3 b 128 ˘ 1 a
27 Guavin A 263 ˘ 9 c 357 ˘ 8 b 518 ˘ 15 a
28 Casuarinin/Casuarictin Isomer 1297 ˘ 5 c 1568 ˘ 10 b 2089 ˘ 11 a
29 Galloyl(epi)catechin-(epi)gallocatechin 61 ˘ 5 c 135 ˘ 1 b 211 ˘ 12 a
30 Procyanidin pentamer <LOQ <LOQ <LOQ
31 Galloyl-(epi)catechin trimer Isomer <LOQ <LOQ <LOQ
32 Gallocatechin 2074 ˘ 2 b 1526 ˘ 2 c 2613 ˘ 55 a
33 Tellimagrandin I Isomer 463 ˘ 2 c 516 ˘ 6 b 737 ˘ 24 a
34 Vescalagin 160 ˘ 6 b 159 ˘ 3 b 187 ˘ 1 a
35 Stenophyllanin A Isomer 355.36 ˘ 0.07 c 425 ˘ 13 b 548 ˘ 20 a
36 Galloyl-(epi)catechin trimer Isomer <LOQ <LOQ <LOQ
37 Myricetin hexoside Isomer 432.10 ˘ 0.05 c 555 ˘ 2 b 572 ˘ 7 a
38 Stachyuranin A 207.40 ˘ 0.04 a 207 ˘ 6 a 216 ˘ 1 a
39 Procyanidin gallate Isomer 533.2 ˘ 0.07 c 799 ˘ 3 b 1036 ˘ 32 a
40 Myricetin hexoside Isomer 213 ˘ 2 c 288 ˘ 2 b 307.8 ˘ 0.8 a
41 Vescalagin/castalagin Isomer 152 ˘ 3 b 155 ˘ 2 b 191 ˘ 3 a
42 Myricetin arabinoside/xylopyranoside Isomer 241 ˘ 5 c 286 ˘ 2 b 306 ˘ 5 a
43 Myricetin arabinoside/xylopyranoside Isomer 608 ˘ 1 c 839 ˘ 8 b 946 ˘ 11 a
44 Procyanidin gallate Isomer 11 ˘ 1 a 3.7 ˘ 0.2 b <LOQ
45 Myricetin arabinoside/xylopyranoside Isomer 688 ˘ 16 c 816.0 ˘ 0.5 b 874 ˘ 9 a
46 Myricetin hexoside Isomer 1186 ˘ 13 a 1010 ˘ 3 b 1012 ˘ 65 b
47 Myricetin hexoside Isomer 200 ˘ 3 b 208 ˘ 5 b 224 ˘ 6 a
48 Myricetin arabinoside/xylopyranoside Isomer 276.0 ˘ 0.9 a,b 266 ˘ 3 b 282 ˘ 8 a
49 Quercetin galloylhexoside Isomer 375.0 ˘ 0.6 b 380 ˘ 5 b 438 ˘ 18 a
50 Ellagic acid deoxyhexoside 700 ˘ 1 a 702 ˘ 12 a 733 ˘ 32 a
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Table 1. Cont.
No. Compound High Medium Low
Negative mode Concentration (µg compound/g leaf d.w.)
51 Quercetin galloylhexoside Isomer 180 ˘ 2 b 194 ˘ 7 a 205 ˘ 1 a
52 Myricetin arabinoside/xylopyranoside Isomer 544.3 ˘ 0.4 b 525 ˘ 2 b 588 ˘ 18 a
53 Morin 2619 ˘ 4 c 3206 ˘ 11 b 4474 ˘ 98 a
54 Myricetin arabinoside/xylopyranoside Isomer 611 ˘ 4 a 581 ˘ 6 b 559 ˘ 3 c
55 Ellagic acid 1229 ˘ 26 c 1345 ˘ 34 b 1759.6 ˘ 0.9 a
56 Hyperin 11305 ˘ 27 c 11906 ˘ 57 b 12528 ˘ 83 a
57 Quercetin glucuronide <LOQ <LOQ <LOQ
58 Isoquercitrin 2254 ˘ 10 b 2471 ˘ 16 b 3410 ˘ 38 a
59 Procyanidin gallate Isomer <LOQ 7.3 ˘ 0.3 b 73.3 ˘ 0.2 a
60 Reynoutrin 2641 ˘ 11 b 2762 ˘ 2 b 3210 ˘ 104 a
61 Guajaverin 8864 ˘ 8 b 9668 ˘ 64 b 11813 ˘ 64 a
62 Guavinoside A 783 ˘ 5 a,b 770 ˘ 4 b 793 ˘ 4 a
63 Avicularin 10353 ˘ 18 a,b 10173 ˘ 54 b 11441 ˘ 63 a
64 Quercitrin 213 ˘ 2 b 208 ˘ 2 b 223 ˘ 1 a
65 Myrciaphenone B 546 ˘ 6 c 621 ˘ 1 b 715 ˘ 20 a
66 Guavinoside C 2069 ˘ 1 b 1966 ˘ 21 c 2209 ˘ 21 a
67 Guavinoside B 872 ˘ 17 c 1035 ˘ 23 b 1273 ˘ 30 a
68 Guavinoside A Isomer 137 ˘ 1 a 135.1 ˘ 0.6 a 137 ˘ 3 a
69 Guavinoside B Isomer 120 ˘ 2 b 119,6 ˘ 0.2 b 129 ˘ 1 a
70 2,6-dihydroxy-3-methyl-4-O-(6”-O-galloyl-β-D-glucopyranosyl)-benzophenone 1179 ˘ 12
b 1242 ˘ 33 b 1365 ˘ 20 a
71 Guavin B 220.51 ˘ 0.03 b 230.1 ˘ 0.7 a,b 241 ˘ 7 a
72 Quercetin 258 ˘ 4 a 253 ˘ 3 a 255 ˘ 5 a
73 Naringenin 487 ˘ 3 c 638 ˘ 24 b 705 ˘ 6 a
Positive mode Concentration (µg compound/g leaf d.w.)
74 Cyanidin-3-O-glucoside 441.28 ˘ 0.04 a 169.3 ˘ 0.5 b 29.5 ˘ 0.2 c
LOQ: limits of quantification; means in the same line with different letter (a,b,c) are significantly different
(p < 0.05).
Int. J. Mol. Sci. 2016, 17, 699 5 of 13
Int. J. Mol. Sci. 2016, 17, 699 5 of 13 
 
 
Figure 1. Fragmentation pattern of cyanidin-3-O-glucoside. MS/MS spectra has been obtained by auto MS/MS fragmentation. Figure 1. Fragmentation pattern of cyanidin-3-O-glucoside. MS/ S spectra has been obtained by auto S/
Int. J. Mol. Sci. 2016, 17, 699 6 of 13
Several works reported the quantification of some compounds such as ellagic acid, quercetin,
gallic acid, catechin, and gallocatechin by HPLC-DAD in guava leaves [3,9,12,19]. Comparing
the results, compounds in dried leaves are found in lower quantities than in the extract [3,12],
although values in the same order of magnitude are noticed for quercetin [9] and greater amounts
of catechin and gallocatechin are found comparing values with those obtained for dried leaves
from Korea [19]. Furthermore, Zhu and coworkers [20] also isolated the major compounds in
Chinese guava leaves: hyperoside, isoquercitrin, reynoutrin, guajaverin, avicularin, and also
2,4,6-trihydroxy-3,5-dimethylbenzophenone 4-O-(6”-O-galloyl)-β-D-glucopyranoside. Concentrations
of reynoutrin, guajaverin, and avicularin isomers followed the same order as in the present
leaves (reynoutrin < guajaverin < avicularin) and the opposite order was observed for the other
isomers (isoquercitrin < hyperin). The compound 2,4,6-trihydroxy-3,5-dimethylbenzophenone
4-O-(6”-O-galloyl)-β-D-glucopyranoside was not detected in the present samples, in contrast,
2,6-dihydroxy-3-methyl-4-O-(6”-O-galloyl-β-D-glucopyranosyl)-benzophenone could be found.
Differences noticed between these works could be because phenolic composition vary substantially
among genotypes, seasons changes, ages, and damaged leaves, and location sites [7]. Regarding the
different families present in leaves, extracts reported significant differences (p < 0.05), the lowest content
of the different classes of phenolic compounds were found in leaves at the highest oxidation state,
whereas the highest content was found in leaves at the lowest oxidation state (Figure 2). The major class
of phenolic compounds in guava leaves samples was flavonols that ranged between 48.1 and 50.6 mg/g
leaf d.w. The second class of polar compounds was represented by flavan-3-ols (24.2–24.7 mg/g
leaf d.w.), followed by gallic and ellagic acid derivatives (14.8–15.8 mg/g leaf d.w.) and finally, by
flavanones, that varied from 0.49 to 0.63 mg/g leaf d.w. Indeed, the contribution of reynoutrin,
guajaverin, and avicularin isomers to total phenolic content (TPC) was predominant in this work,
corresponding, on average, to 25% and 26% of the TPC, followed by hyperin and isoquercitrin, which
supposed about 15%. Furthermore, myricetin derivatives contributed on 5% to TPC, morin and
quercetin account between 3% and 5% of TPC from the different samples. Moreover, catechin was
ranged between 7% and 10%, gallocatechin isomers varied between 7% and 8% of the total amount,
and procyanidin B isomers represented a 6%.
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Figure 2. Quantification of different families of phenolic compounds present in guava leaves at different
oxidative states. The different letter (a,b,c) in the same phenolic class means a significant difference
(p ď 0.05).
The variance in concentration of the individual compounds (Table 1), and the differences between
the families (Figure 2) is probably resulting from the different synthesis of secondary metabolites as
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response to the oxidative state of the leaves [9] and it could be explained by the formation of the
compounds in the flavonoid pathway [21,22]. Most of the compounds present in guava leaves derivate
from dihydroquercetin, precursor of both anthocyanins and flavonols. In fact, it has been noticed
that leaves with low oxidation state presented greater amounts of flavonols, such as quercetin and
myricetin derivatives, whereas the contents of the flavan-3ols catechin and gallocatechin, and the
content of cyanidin-3-O-glucoside were lower. In contrast, the highest oxidative state showed lower
amounts of quercetin and myricetin derivatives than low oxidation state, and higher concentration of
catechin, gallocatechin, and cyanidin-3-O-glucoside than low oxidized leaves (Table 1). Chang et al. [16]
also found for guava budding leaf tea that the presence of quercetin and its glycosides was larger than
catechins and myricetin derivatives. Moreover, the increasing concentration of cyanidin-3-O-glucoside
explained the dramatic red coloration of the leaves at higher oxidative states [21–23].
P. guajava leaves have traditionally been used in many countries to manage, control, and treat
the diabetes [24], and its potential against diabetes mellitus type 2 has also been demonstrated in
several works by the different parts of the plant, such as fruit, peel, pulp, seeds, and stem bark [25–28].
Singh et al. [29] reported that flavonoids are one of the major chemical constituents of plant species
used in the management of diabetic complications. In fact, the anti-diabetic activity has mainly been
attributed to a synergistic effect of the phenolic compounds present in the leaves [30]. This effect
has been observed in half ripen guava fruit for in vitro and in vivo assays [25]. Authors reported
that the effect is due to the total phenolic and flavonoid content in the fruit that was 40.13 ˘ 2.12
and 18.43 ˘ 1.22 mg/g of dry weight sample, respectively. Moreover, the recovery of total phenolic
compounds in the peel was 58.7 ˘ 4.0 g gallic acid equivalent (GAE)/kg dry matter [31]. Ribeiro
da Silva and coworkers [32] reported that the phenolic contents in the pulp was 1723.06 ˘ 111.58 mg
GAE/100 g dry basis; in the seeds varied between 14.54 and 91.05 mg total phenols (TP)/100 g
of defatted ground seeds in several solvents [33]; and the TPC of the stem bark, determined by
Folin–Ciocalteu, was 1.15 ˘ 0.12 g GAE/100 g dry weight [34]. These values are lower than the
ones summarized in the present work, so it could be supposed that guava leaves could be better
anti-diabetic agents than the other parts of the plant.
Comparing the phenolic content of guava leaves to other plant leaves, different evidence has
been found. The ethanol extract from Telfairia occidentalis leaves has also exhibited anti-hyperglycemic
activity and has demonstrated strong inhibition of α-glucosidase and mild inhibition of α-amylase [35].
Authors related its activity to the phenolic and flavonoid content; however, its content was less than
three order of magnitude than that reported in the present work. Additionally, other plants such as
Teucrium polium, cinnamon and garlic, have generally presented lower phenolic contents than guava
leaves [36–38] are also widely used in folk medicine for the treatment of diabetes [25]. In fact, different
extracts from Teucrium polium (leaves, flowers, and stems) reported a TPC between 14.6 to 157.8 mg of
GAE/g of extract [36], different parts of Cinnamomum cassia (barks, buds, and leaves) exhibited values
for TPC from 6.3 to 9.5 g/100 g d.w. [37], and 3.4–10.8 mg GAE/g d.w. was the range of TPC found for
different cultivars of garlic [38]. Additionally, several individual compounds isolated from different
sources that have also been found in guava leaves have demonstrated anti-diabetic properties (Table 2).
The principal activities related to these compounds are the inhibition of carbohydrate-hydrolysing
enzymes due to the presence of myrciaphenone B [39], casuarictin and tellimagrandin I [40],
flavonol glycosides (hyperin, isoquercitrin, reynoutrin, guajaverin, avicularin) [30,41], geraniin and
catechin [42], quercetin [30], and cyanidin-3-O-β-glucoside [43]. Insulinomimetic activity has been
attached to casuarinin, casuariin [40], procyanidin oligomers [44], and pedunculagin [45]. Moreover,
geraniin, vescalagin, gallic acid, naringenin, morin, quercetin, catechin, epicatechin, and procyanidin
B2 [42] exhibited anti-glycation activity, due to the inhibition of the formation of Amadori products and
advanced glycation end-products (AGEs). At last, the improvement of postprandial hyperglycemia
has been related to catechin and gallocatechin, among others [46].
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Table 2. Guava leaves’ bioactive compounds related with anti-diabetic properties.
Compound Assay Activity Ref.
Myrciaphenone B in vivo Inhibition of aldose reductase α-glucosidase [39]
Casuarictin, tellimagrandin I in vitro Inhibition of α-glucosidase [40]
Cyanidin-3-O-β-glucoside in vitro/in silico Inhibition of α-amylase [43]
Flavonol glycosides in vitro Inhibition of dipeptidyl-peptidase IV, and α-glucosidaseand α-amylase [30,41]
Geraniin in vitro
Hypoglycemic activity; inhibition of carbohydrate-hydrolysing
enzymes (α-glucosidase and α-amylase); effective in preventing
advanced glycation end-products (AGEs) formation
[42]
Vescalagin in vivo Retard AGEs formation [42]
Gallic acid in vitro
Inhibitory effect on the formation of α-dicarbonyl compounds
and protein glycation: inhibitory effects on the production of
Amadori products and AGEs
[3,42]
Naringenin in vitro Anti-glycation activity [42]
Morin in vitro Protective activity against glycation [42]
Quercetin in vitro
Inhibitory effect on protein glycation, on the formation of
α-dicarbonyl compounds, and on the production of Amadori
products and AGEs
[3,30,42]
Catechin in vitro/in vivo/clinical trial
Inhibitory effect on the formation of α-dicarbonyl compounds
and protein glycation: inhibitory effects on the production of
Amadori products and AGEs; improvement of
postprandial hyperglycaemia
[42,46]
Procyanidin B2 in vitro/in vivo Inhibitory effects on the formation of AGEs [42]
Casuarinin, casuariin in vitro Inhibition of insulin-like glucose uptake [40]
Procyanidin oligomers in vitro/in vivo Insulinomimetic properties [44]
Pedunculagin in vivo Improvement sensitivity of insulin [45]
Gallocatechin clinical trial Improvement of postprandial hyperglycaemia [46]
2.2. Antioxidant Capacity and Total Phenolic Content
The evaluation of the antioxidant capacity is usually done comparing different methods in
order to take into account the large number of factors that can influence the antioxidant action [47].
The choice of the two methods used in this work were assessed based on their different mechanisms:
Trolox Equivalent Antioxidant Capacity (TEAC) assay estimates the ability to scavenge 2,21-azinobis
(3-ethylbenzothiazoline-6-sulfonate) (ABTS‚+) radicals and ferric reducing capacity is evaluated by the
Ferric Reducing Antioxidant Power (FRAP) method. As is shown in Table 3, significant differences
have been found among the different oxidation states (p < 0.05), the lowest oxidation states reported the
highest values for TEAC and FRAP (3.1 ˘ 0.1 mM eq Trolox/mg leaf d.w. and 5.4 ˘ 0.1 mM FeSO4/mg
leaf d.w., respectively) and decrease as the oxidation state increases. Comparing the results with those
reported by Tachakittirungrod and coworkers [48] for guava leaves, similar values were accomplished
for TEAC and higher values for FRAP. This can be due to the fact that phenolic compounds in Spanish
leaves are more involved in the mechanism of reduction of oxidized intermediates in the chain reaction.
Table 3. Comparison (mean ˘ SD, n = 3) among total phenolic content (TPC) by HPLC-DAD-ESI-
QTOF-MS, Trolox Equivalent Antioxidant Capacity (TEAC) and Ferric Reducing Antioxidant Power
(FRAP) of Psidium guajava L. leaves at different oxidative states.
Oxidation State TPC (mg/g leaf d.w.) TEAC(mM eq Trolox/mg leaf d.w.)
FRAP
(mM FeSO4/mg leaf d.w.)
High 87.91 ˘ 0.05 c 2.2 ˘ 0.2 c 3.69 ˘ 0.03 c
Medium 92.0 ˘ 0.4 b 2.44 ˘ 0.05 b 4.20 ˘ 0.06 b
Low 103 ˘ 2 a 3.1 ˘ 0.1 a 5.4 ˘ 0.1 a
Means in the same column with different letter (a,b,c) are significantly different (p < 0.05).
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Moreover, high correlation was found between the antioxidant assays (r = 0.9978 and p < 0.001),
in concordance with the data obtained for guava leaves [49], fruits [50], and in 30 plant extracts
of industrial interest [51]. However, TEAC value seems to be higher than FRAP value for guava
leaves [12,14,48].
Quantification of total phenolic compounds by HPLC-DAD-ESI-QTOF-MS revealed that the three
extracts showed significant differences (p < 0.05) as is displayed in Table 3. The lowest oxidation state
provided the highest content of total phenolic compounds (103 ˘ 2 mg/g leaf d.w.), followed by the
medium and the highest oxidation state (92.0 ˘ 0.4 and 87.91 ˘ 0.04 mg/g leaf d.w., respectively).
The values obtained were lower than those reported by several authors that employed Folin–Ciocalteu
method to quantify total phenolic compounds [12,14]. Even though the variance noticed is not great,
it could be because the determination by HPLC presented only 50–60 percentage of total phenolic
content [12]. Additionally, high correlation among TPC by HPLC, FRAP, and TEAC assays were found
in the present work. In fact, positive correlation with r = 0.9921 (p < 0.001) was noticed between TPC
by HPLC and FRAP and r = 0.9867 (p < 0.001) for TPC by HPLC and TEAC. Good correlations were
also found between TPC by Folin–Ciocalteu and antioxidant activity was also noticed for guava leaves
in literature [12,14,48].
3. Materials and Methods
3.1. Plant Material and Sample Preparation
Fresh guava leaves were harvested in Motril, Spain (36˝44143”N 3˝31114”W). The leaves were
collected in February 2014 at different oxidation states (low, medium, and high) based on the
difference of leaf color according to Hao [8]. The samples were air-dried at room temperature,
ground, and extracted with ethanol:water 80/20 (v/v) by ultrasonics as was previously reported by
Díaz-de-Cerio et al. [18].
3.2. Antioxidant Capacity Analysis
Trolox Equivalent Antioxidant Capacity (TEAC) and Ferric Reducing Antioxidant Power (FRAP)
analysis were used to measure the antioxidant capacity.
For TEAC, ABTS radical cation was generated by reacting ABTS stock solution with 2.45 mM
potassium persulfate in the dark at room temperature for 12–24 h before use. A calibration curve was
prepared with different concentrations of Trolox (0–20 µM). The absorbance of ABTS radical cation
was adjusted to 0.70 (˘0.02) at 734 nm, and its change was measured [52].
To evaluate the reducing power, FRAP reagent (containing 2,4,6-tripyridyl-S-triazine (TPTZ),
FeCl3 and acetate buffer) was prepared. An aqueous solution of Fe (II) was used for calibration
(12.5–200 µM). The reduction was measured at 593 nm [53].
Results are expressed as mM eq Trolox/mg leaf d.w. and mM FeSO4/mg leaf d.w., respectively.
3.3. HPLC-DAD-ESI-QTOF-MS Analysis
Chromatographic analyses were performed using an HPLC Agilent 1260 series (Agilent
Technologies, Santa Clara, CA, USA) equipped with a binary pump, an online degasser, an autosampler,
a thermostatically-controlled column compartment, and a UV-VIS diode array detector (DAD).
The column was maintained at 25 ˝C. Phenolic compounds from P. guajava L. leaves were separated
using a method previously reported by Gómez-Caravaca et al. [54], in positive mode, slightly modified.
Briefly, a fused-core Poroshell 120, SB-C18 (3.0 mm ˆ 100 mm, 2.7 µm) from Agilent Technologies
(Agilent Technologies, Palo Alto, CA, USA) was used. The mobile phases were water plus 1% acetic
acid (A) and acetonitrile (B). A multi-step linear gradient was applied as follows; 0 min, 5% B; 2 min,
7% B; 4 min, 9% B; 6 min, 12% B; 8 min, 15% B; 9 min, 16% B; 10 min, 17% B; 11 min, 17.5% B; 12 min,
18% B; 13 min, 100% B; 17 min, 100% B; 18 min, 5% B. The initial conditions were maintained for 5 min.
The sample volume injected was 3 µL and the flow rate used was 0.8 mL¨ min´1.
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MS analyses were carried out using a 6540 Agilent Ultra-High-Definition Accurate-Mass
Q-TOF-MS coupled to the HPLC, equipped with an Agilent Dual Jet Stream electrospray ionization
(Dual AJS ESI) interface, at the following conditions: drying gas flow (N2), 12.0 L/min; nebulizer
pressure, 50 psi; gas drying temperature, 370 ˝C; capillary voltage, 3500 V; fragmentor voltage and
scan range were 3500 V and m/z 50–1700. In positive mode, auto MS/MS experiments were carried
out using the followings collision energy values: m/z 100, 40 eV; m/z 500, 45 eV; m/z 1000, 50 eV;
and m/z 1500, 55 eV.
Additionally, phenolic compounds were also analyzed in negative mode using the
chromatographic and the detection method described by Díaz-de-Cerio et al. [18].
Standard calibration curves for cyanidin-3-O-β-galactopyranoside, gallic acid, catechin, ellagic
acid, naringenin, and rutin were prepared in the range of concentrations from the limit of quantification
(LOQ) to 50 mg/L and five calibration points for each standard were run in triplicate (n = 3).
Integration and data elaboration were performed using MassHunter Workstation software
(Agilent Technologies).
3.4. Statistical Analysis
The results reported in this study are the averages of three repetitions (n = 3). Fisher’s least
significance difference (LSD) test and Pearson’s linear correlations, both at p < 0.05, were evaluated
using Statistica 6.0 (2001, StatSoft, Tulsa, OK, USA).
4. Conclusions
HPLC coupled to QTOF-MS detector, which provides a molecular formula and the MS/MS data,
permitted the analysis of the major phenolic compounds of guava leaves. The method performed in
negative mode has proven to be successful in determining 73 compounds in the different guava leaves.
Moreover, in positive mode, the analysis with QTOF analyzer and the co-elution with a standard
solution allowed the identification of the cyanidin-glucoside. To our knowledge the cyanidin-glucoside,
was identified for the first time in guava leaves. Quantification data, in negative mode, reported that
leaves with low oxidation state presented the highest concentration of these compounds and decreased
when the oxidation state raise. On the contrary, the state of oxidation affected significantly the cyanidin
content. In fact, highest amount was detected in the leaves with high oxidation state.
Guava leaves seem to be a good source of phenolic compounds with described anti-diabetic
properties since several compounds present in the leaves have been related for ameliorating the effects
of diabetes mellitus disease, although this content varies due to the oxidative state of the leaf, so further
studies should be carried out in order to evaluate the influence of the phenolic composition on the
bioactivity of the extract.
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